α-Mercaptoketone based histone deacetylase inhibitors
摘要:
In an effort to discover novel non-hydroxamic acid histone deacetylase (HDAC) inhibitors, a novel alpha-mercaptoketone was identified in a high-throughput screen. Lead optimization of the screening hit, led to a number of potent HDAC inhibitors. In particular, alpha-mercaptoketone 19y (KD5150) exhibited nanomolar in vitro activity and inhibition of tumor growth in vivo. (C) 2008 Elsevier Ltd. All rights reserved.
Antiviral properties and interaction of novel chalcone derivatives containing a purine and benzenesulfonamide moiety
作者:Dagui Zhou、Dandan Xie、Fangcheng He、Baoan Song、Deyu Hu
DOI:10.1016/j.bmcl.2018.04.042
日期:2018.6
A new concise and facile method was explored to synthesize a series of novel chalcone derivatives containing a purine and benzenesulfonamide moiety and their antiviral properties were evaluated against TMV and CMV. Biological assays indicated that several of the derivatives exhibited significant anti-TMV and anti-CMV activities in vivo. In particular, compound d2 displayed excellent inactivating activity against TMV, with the EC50 value of 51.65 mu g/mL, which was better than that of ribavirin (150.45 mu g/mL). Molecular docking showed that there are four hydrogen bonds between compound d2 and TMV coat protein (TMV-CP). Compound d2 demonstrated strong binding capacity to TMV-CP with K-a = 1.58 x 10(5) L/mol and K-d = 12.16 mu M. These findings indicated that chalcone derivatives are worthy of further research and development as templates for new antiviral agents. (C) 2018 Elsevier Ltd. All rights reserved.
α-Mercaptoketone based histone deacetylase inhibitors
作者:Paul L. Wash、Timothy Z. Hoffman、Brandon M. Wiley、Céline Bonnefous、Nicholas D. Smith、Michael S. Sertic、Charles M. Lawrence、Kent T. Symons、Phan-Manh Nguyen、Kevin D. Lustig、Xin Guo、Tami Annable、Stewart A. Noble、Jeffrey H. Hager、Christian A. Hassig、James W. Malecha
DOI:10.1016/j.bmcl.2008.10.058
日期:2008.12
In an effort to discover novel non-hydroxamic acid histone deacetylase (HDAC) inhibitors, a novel alpha-mercaptoketone was identified in a high-throughput screen. Lead optimization of the screening hit, led to a number of potent HDAC inhibitors. In particular, alpha-mercaptoketone 19y (KD5150) exhibited nanomolar in vitro activity and inhibition of tumor growth in vivo. (C) 2008 Elsevier Ltd. All rights reserved.